TransEnterix (TRXC) Misses Q3 EPS by 17c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. FISV
10. CVS

Go back to TransEnterix (TRXC) Misses Q3 EPS by 17c

TransEnterix, Inc. Reports Operating Results for the Third Quarter 2017

November 9, 2017 4:05 PM EST

Received U.S. FDA 510(k) clearance for the Senhance Surgical System October 13, 2017 Cash and Restricted Cash of over $100 million as of October 31, 2017

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced its operating and financial results for the third quarter of 2017.

We are very excited about the progress we made during the third quarter and the 510(k)... More